[
  {
    "ts": "2025-10-13T19:24:00+00:00",
    "headline": "Trump’s AstraZeneca Deal Echoes Pfizer Pact. Big Pharma’s Political Headaches Are Easing.",
    "summary": "The Trump administration has promised to delay sector-specific tariffs for both firms, and more drugmakers could join the club.",
    "url": "https://www.barrons.com/articles/trump-astrazeneca-stock-pfizer-big-pharma-6ab9cebb?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "deb963a6-f3c4-3c78-8985-ec9546403f84",
      "content": {
        "id": "deb963a6-f3c4-3c78-8985-ec9546403f84",
        "contentType": "STORY",
        "title": "Trump’s AstraZeneca Deal Echoes Pfizer Pact. Big Pharma’s Political Headaches Are Easing.",
        "description": "",
        "summary": "The Trump administration has promised to delay sector-specific tariffs for both firms, and more drugmakers could join the club.",
        "pubDate": "2025-10-13T19:24:00Z",
        "displayTime": "2025-10-13T19:24:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/deb963a6-f3c4-3c78-8985-ec9546403f84/trump%E2%80%99s-astrazeneca-deal.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/3a19f63d76173e45252b25a4130abd97",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/u2.6T6Fzy.3Pf_MVRBEJuA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/3a19f63d76173e45252b25a4130abd97.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Hag.vk95pOKArV.yv17ZMA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/3a19f63d76173e45252b25a4130abd97.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/trump-astrazeneca-stock-pfizer-big-pharma-6ab9cebb?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AZN"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "XBI"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "AZN.L"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-13T14:57:04+00:00",
    "headline": "New US biotech hubs show potential amid onshoring requests",
    "summary": "While established US biotech hubs may still rule the roost, emerging competitors are looking to grab a larger slice of the market.",
    "url": "https://www.pharmaceutical-technology.com/features/new-us-biotech-hubs-showing-potential-amid-onshoring-request/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "8590c696-124a-3d80-bc5d-fea7a31dd644",
      "content": {
        "id": "8590c696-124a-3d80-bc5d-fea7a31dd644",
        "contentType": "STORY",
        "title": "New US biotech hubs show potential amid onshoring requests",
        "description": "",
        "summary": "While established US biotech hubs may still rule the roost, emerging competitors are looking to grab a larger slice of the market.",
        "pubDate": "2025-10-13T14:57:04Z",
        "displayTime": "2025-10-13T14:57:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/555747cdccb147b00f8354c36e57875e",
          "originalWidth": 1000,
          "originalHeight": 750,
          "caption": "The shifting geopolitical landscape in the US amid Trump's presidency may be impacting where biotech and pharma companies choose to place their operations. Image credit: Maxx-Studio via ShutterStock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mOeJjHlH8_s_5o4qRguo1A--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/555747cdccb147b00f8354c36e57875e.cf.webp",
              "width": 1000,
              "height": 750,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VI5lSQ3VZ7zoaqOuxoCp6A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/555747cdccb147b00f8354c36e57875e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/features/new-us-biotech-hubs-showing-potential-amid-onshoring-request/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/us-biotech-hubs-showing-potential-145704693.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-13T12:50:00+00:00",
    "headline": "Will the Orbital Acquisition Strengthen BMY's Cell Therapy Portfolio?",
    "summary": "Bristol Myers' $1.5B buyout of Orbital Therapeutics expands its cell therapy reach with a next-gen in vivo CAR T candidate and advanced RNA platform.",
    "url": "https://finance.yahoo.com/news/orbital-acquisition-strengthen-bmys-cell-125000332.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "d08af608-9016-3254-9ab8-062647bc0216",
      "content": {
        "id": "d08af608-9016-3254-9ab8-062647bc0216",
        "contentType": "STORY",
        "title": "Will the Orbital Acquisition Strengthen BMY's Cell Therapy Portfolio?",
        "description": "",
        "summary": "Bristol Myers' $1.5B buyout of Orbital Therapeutics expands its cell therapy reach with a next-gen in vivo CAR T candidate and advanced RNA platform.",
        "pubDate": "2025-10-13T12:50:00Z",
        "displayTime": "2025-10-13T12:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AZ1NFKr1Arip4UWINeWStw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zL5_evNVQm1N5N.bc6WldQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/orbital-acquisition-strengthen-bmys-cell-125000332.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/orbital-acquisition-strengthen-bmys-cell-125000332.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "NVSEF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-13T10:59:00+00:00",
    "headline": "Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types",
    "summary": "PRINCETON, N.J., October 13, 2025--Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-present-data-105900432.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "6bb8f096-be65-37f5-a4c5-fac1e103974c",
      "content": {
        "id": "6bb8f096-be65-37f5-a4c5-fac1e103974c",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types",
        "description": "",
        "summary": "PRINCETON, N.J., October 13, 2025--Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types",
        "pubDate": "2025-10-13T10:59:00Z",
        "displayTime": "2025-10-13T10:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/926e6e0762eefab4e6cbbdbfbc70c036",
          "originalWidth": 1497,
          "originalHeight": 206,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2ODgs.u7uATjAYHrl6VJ4w--~B/aD0yMDY7dz0xNDk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/926e6e0762eefab4e6cbbdbfbc70c036.cf.webp",
              "width": 1497,
              "height": 206,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EdY25w9CEjzT0zFdv9fRkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/926e6e0762eefab4e6cbbdbfbc70c036.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-present-data-105900432.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-present-data-105900432.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-13T09:00:00+00:00",
    "headline": "SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration",
    "summary": "SystImmune, Inc., a clinical-stage biotechnology company, today announced the treatment of the first patient in the IZABRIGHT-Breast01 study (NCT06926868), a global Ph2/3 registrational study of izalontamab brengitecan (iza-bren) in previously untreated triple negative breast cancer ineligible for anti-PD(L)1 drugs. This milestone triggered a one-time payment of $250 million by Bristol Myers Squibb (NYSE: BMY), pursuant to the 2023 collaboration and exclusive license agreement between SystImmune",
    "url": "https://finance.yahoo.com/news/systimmune-receive-milestone-payment-bristol-090000349.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "b5e3e93b-687f-3e2a-9e92-6c972efa1f81",
      "content": {
        "id": "b5e3e93b-687f-3e2a-9e92-6c972efa1f81",
        "contentType": "STORY",
        "title": "SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration",
        "description": "",
        "summary": "SystImmune, Inc., a clinical-stage biotechnology company, today announced the treatment of the first patient in the IZABRIGHT-Breast01 study (NCT06926868), a global Ph2/3 registrational study of izalontamab brengitecan (iza-bren) in previously untreated triple negative breast cancer ineligible for anti-PD(L)1 drugs. This milestone triggered a one-time payment of $250 million by Bristol Myers Squibb (NYSE: BMY), pursuant to the 2023 collaboration and exclusive license agreement between SystImmune",
        "pubDate": "2025-10-13T09:00:00Z",
        "displayTime": "2025-10-13T09:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/a2c51215c5ec63b757111724cd5e99fd",
          "originalWidth": 400,
          "originalHeight": 200,
          "caption": "(PRNewsfoto/SystImmune Inc.)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9O6MLWScjve8x12UaJ5fdQ--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/a2c51215c5ec63b757111724cd5e99fd.cf.webp",
              "width": 400,
              "height": 200,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w3IY14xgSYxhxZXyRr5iJA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/a2c51215c5ec63b757111724cd5e99fd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/systimmune-receive-milestone-payment-bristol-090000349.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/systimmune-receive-milestone-payment-bristol-090000349.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]